Qiagen NV | QIA - Debt

Stock Price
41.39
Daily Change
0.21 0.51%
Monthly
-9.00%
Yearly
11.07%
Q1 Forecast
40.37

Qiagen NV reported $2.13B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
argenx SE USD 43.15M 4.1M Jun/2025
Avita Medical AUD 44.59M 1.4M Jun/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Moderna USD 734M 7M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Qiagen NV USD 2.13B 683.16M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.41B 25.6M Dec/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025